Log in/ Sign up

Novo Nordisk will slash US list prices of its blockbuster diabetes and weight-loss drugs Ozempic and Wegovy by up to 35% and 50% respectively starting next year, said the Danish drugmaker. READ MORE

25/02 01:15
Bullish
Bearish

Trending News